It is worthy to further investigate whether BCRP/ABCG2 expression is also induced in response to chronic treatment with sorafenib and thereby contributes to the Akt-mediated intrinsic and acquired resistance to sorafenib in HCC [39]. Here, ABCG2 is linked to hepatocellular carcinoma.